Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Pharmaceuticals Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.125p -0.86% 14.40p 14.40p 14.65p 14.70p 14.40p 14.45p 122,728 11:23:36
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 48.3 -55.8 -34.0 - 54.00

Circassia Pharmaceuticals Plc Annual report and notice of AGM

14/05/2019 4:24pm

UK Regulatory (RNS & others)


Circassia Pharmaceuticals (LSE:CIR)
Historical Stock Chart

2 Months : From Apr 2019 to Jun 2019

Click Here for more Circassia Pharmaceuticals Charts.

TIDMCIR

RNS Number : 0190Z

Circassia Pharmaceuticals Plc

14 May 2019

For immediate release

Circassia Pharmaceuticals plc

Annual Report and Accounts for the year ended 31 December 2018 and Notice of 2019 Annual General Meeting

14 May 2019

Circassia Pharmaceuticals plc announces that its Annual Report and Accounts for the year ended 31 December 2018 and Notice of 2019 Annual General Meeting have been published on the Company's website: www.circassia.com. Additionally, these documents have been posted, or otherwise made available, to shareholders.

The Annual General Meeting will be held at 12.00 midday on Friday 7 June 2019 at the Company's offices: Northbrook House, Robert Robinson Avenue, Oxford, OX4 4GA.

Contacts

Circassia

Steven Harris, Chief Executive Officer Tel: +44 (0) 1865 405 560

Julien Cotta, Chief Financial Officer

Rob Budge, Corporate Communications

Peel Hunt (Nominated Adviser and Joint Broker)

James Steel / Dr Christopher Golden Tel: +44 (0) 20 7418 8900

Numis Securities (Joint Broker)

James Black / Freddie Barnfield Tel: +44 (0) 20 7260 1000

FTI Consulting

Simon Conway / Ciara Martin Tel: +44 (0) 20 3727 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCUSUVRKRAVAAR

(END) Dow Jones Newswires

May 14, 2019 11:24 ET (15:24 GMT)

1 Year Circassia Pharmaceuticals Chart

1 Year Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart
Your Recent History
LSE
CIR
Circassia ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190627 11:14:30